Showing 1161-1170 of 5804 results for "".
DermWireTV: Pfizer, AbbVie JAKs for AD; Spray-on-Skin; Lubriderm Scholarships
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pfizer-abbvie-jaks-for-ad-spray-on-skin-lubriderm-scholarships/20043/For the treatment of refractory moderate-to-severe atopic dermatitis, FDA has approved Pfizer’s Cibinqo (abrocitinib) for adults and AbbVie’s Rinvoq (upadacitinib) for patients 12 and older. Researchers at the Houston Methodist Research Institute have paired their patented RNA technologies with AvitGet Ready to Rumble
https://practicaldermatology.com/topics/practice-management/get-ready-to-rumble/23624/Without intervention, dermatologists may face close to a 10 percent reduction in Medicare payments.5 Year Plan: Innovation Update
https://practicaldermatology.com/conferences/asds-2021/5-year-plan-innovation-update/20024/Mat Avram, MD provides an update on newly approved technologies as well as some that could be in use in practice within the next five years to improve outcomes or increase safety.I Invested in One Laser When I Opened My Practice and This is How It Turned Out
https://practicaldermatology.com/topics/general-topics/i-invested-in-one-laser-when-i-opened-my-practice-and-this-is-how-it-turned-out/20017/Medical dermatology is a tough field to scale with numerous competitors in the market but Dr. Joyce Imahiyerobo-Ip found ways to compete. She shares the struggles of starting a new practice and the difficulties of selling aesthetic services as a dermatologist. A key to her success was the Aerolase NDERM2021: An Engaging Learning Experience
https://practicaldermatology.com/series/dermatology-education-foundation/derm2021-an-engaging-learning-experience/19967/Joe Gorelick, MSN, FNP-BC, DEF President, is excited for this year’s DERM2021 NP/PA CME Conference that offers meaningful case studies presented by an advisory panel of dermatology nurse practitioners and physician assistants for an engaging learning experience.Hidradenitis Suppurativa: A Prevalent "Rare" Disease
https://practicaldermatology.com/topics/rare-disease/hidradenitis-suppurativa-a-prevalent-rare-disease/19926/Beyond recognizing that hidradenitis suppurativa is far more prevalent than once believed, research has also elucidated disease mechanisms, comorbidities, and pain pathways. Haley Naik, MD provides important updates on this previously neglected disease.Toxic Attitudes Toward Skin Bleaching
https://practicaldermatology.com/conferences/aad-2021/toxic-attitudes-toward-skin-bleaching/19925/Unregulated ingredients intended for skin lightening and bleaching range from the toxic to the simply unproven. Seemal Desai, MD says dermatologists should educate patients about physician-recommended, well-studied treatments and the risks of unregulated products. He highlights increased attention tSARS-CoV-2 and the Skin: Inside the COVID-19 Dermatology Registry
https://practicaldermatology.com/conferences/aad-2021/sars-cov-2-and-the-skin-inside-the-covid-19-dermatology-registry/19921/From COVID Toes to COVID Arms, dermatologic manifestations of SARS-CoV-2 infection and COVID-19 vaccination abound. Esther Freeman, MD, PhD, Director of the COVID-19 Dermatology Registry provides an overview of findings and shares information about the relatively new vaccine registry.Dermatology SEO trend alert: voice search
https://practicaldermatology.com/topics/practice-management/dermatology-seo-trend-alert-voice-search/19883/One of the hottest trends in internet search is voice-powered technology. What does that mean for your dermatology website? Watch this short video from Ekwa Marketing to find out.Scientifically Speaking: The Truth About Skincare
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-the-truth-about-skincare/19876/From workhorse ingredients like antioxidants and retinol to newer molecules that address pigmentation and aging, there is a lot of noise in the skincare marketplace. And that's without talking about "natural" formulations. Joel L. Cohen, MD gets to the heart of the science, in a conversation with De